Isabella De Souza Mota

Mrs. Isabella De Souza Mota

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
SCSamuel Leite Cardoso
Samuel Leite Cardoso
PSPaula Monteiro Souza
Paula Monteiro Souza
Kelly RodriguesKelly Rodrigues
Kelly Rodrigues
Isabella De Souza MotaIsabella De Souza Mota
Isabella De Souza Mota
EFEdivaldo Ferreira Filho
Edivaldo Ferreira Filho
Perola Oliveira MagalhaesPerola Oliveira Magalhaes
Perola Oliveira Magalhaes
The search for new drug-producing microorganisms is one of the most promising situations in current world scientific scenarios. The use of molecular biology as well as the cloning of protein and compound genes is already well established as the gold standard method of increasing productivity. Aiming at this increase in productivity, this work aims at the cloning, purification and in silico analysis of l-asparaginase from Fusarium proliferatum in Komagataella phaffii (Pichia pastoris) protein expression systems. The l-asparaginase gene (NCBI OQ439985) has been cloned into Pichia pastoris strains. Enzyme production was analyzed via the quantification of aspartic B-hydroxamate, followed by purification on a DEAE FF ion exchange column. The in silico analysis was proposed based on the combined use of various technological tools. The enzymatic activity found intracellularly was 2.84 IU/g. A purification factor of 1.18 was observed. The in silico analysis revealed the position of five important amino acid residues for enzymatic activity, and likewise, it was possible to predict a monomeric structure with a C-score of 1.59. The production of the enzyme l-asparaginase from F. proliferatum in P. pastoris was demonstrated in this work, being of great importance for the analysis of new methodologies in search of the production of important drugs in therapy.

8 October 2025 in Plants
Verified
Journal Article
Open access
PDF file
RARenata Paula Coppini Almeida
Renata Paula Coppini Almeida
SCSamuel Leite Cardoso
Samuel Leite Cardoso
STSeila - Tolentino
Seila - Tolentino
AAArtur Fiuza Borges Arantes
Artur Fiuza Borges Arantes
Isabella De Souza MotaIsabella De Souza Mota
Isabella De Souza Mota
Perola Oliveira MagalhaesPerola Oliveira Magalhaes
Perola Oliveira Magalhaes
Psidium guajava L. (Myrtaceae) is a neotropical species whose leaf extracts demonstrate efficacy against cutaneous and mucosal inflammation and ulceration. This study aimed to prepare and characterize aqueous extracts of P. guajava leaves (EAPG) and incorporate them into chitosan nanoparticles for topical delivery to the oral mucosa. The extract was obtained by infusion, and its marker compound was quantified by a chromatographic method. EAPG exhibited antioxidant activity (IC50: 6.35–7.01 µg/mL in DPPH•; FRAP: 14.42–17.83 µg/mL ≈ 60 µM Fe2+) and anti-inflammatory potential by modulating the expression of IL-6. It also showed antifungal activity against Candida species. Nanoparticles loaded with EAPG had a mean diameter of 899.8 ± 10.8 nm, PdI 0.22 ± 0.03, Zeta potential +32.4 ± 2.3 mV, pH 5.0, and 62 ± 1% encapsulation efficiency. They remained stable for 30 days. In an ex vivo topical application, EAPG nanoparticles delivered 415.17 ± 71.7 µg/cm2 of marker to the oral mucosa, eight times more than free EAPG (p < 0.05). These results suggest that chitosan-based EAPG nanoparticles are a promising strategy for topical treatment of mucosal disorders.